Skip to main content
. Author manuscript; available in PMC: 2011 Aug 28.
Published in final edited form as: Cancer Biol Ther. 2005 May 20;4(5):561–570. doi: 10.4161/cbt.4.5.1670

Table 1.

Design of molecular beacons for detection of e and survivin genes and corresponding target sequences xpression of mutant K-ras

MBs Target sequences Design of the MBs
K-ras MB1 K-ras codon 12 GGT to GAT mutation 5′-Cy 3-CCTACGCCATCAGCTCCGTAGG-Dabcyl-3′
K-ras MB2 K-ras codon 12 GGT to GTT mutation 5′-Texas-red-CCTACGCCAACAGCTCCGTAGG-Dabcyl-3′
Survivin MB1 Survivin cDNA from 27 to 43 nucleotide 5′-Cy3-CTGAGAAAGGGCTGCCAGTCTCAG-Dabcyl-3′
Survivin MB2 Survivin cDNA from 33 to 50 nucleotide 5′-FITC-TGGTCCTTGAGAAAGGGCGACCA-Dabcyl-3′
GAPDH MB GAPDH cDNA from 504 to 521 nucleotide 5′-Cy3-GAGTCCTTCCACGATACCGACTC-Dabcyl-3′

DNA Targets Synthesized Oligonucleotide sequences
K-ras WT (GGT) 5′-GTA GTT GGA GCT GGT GGC GTA GGC AAG AGTGCCTTGACGATACAGCTAATT CAG-3′
K-ras Mut 1 (GAT) 5′-GTA GTT GGA GCT GAT GGC GTA GGC AAG AGTGCCTTGACGATACAGCTAATT CAG-3′
K-ras Mut 2 (GTT) 5′-GTA GTT GGA GCT GTT GGC GTA GGC AAGAGTGCCTTGACGATACAGCTAATT CAG-3′
Survivin 5′-CCTGCCTGGCAGCCCTTTCTCAAGGACCACCGCATCTCTACATTCAAGAAC-3′